Jaxen Report - The HighWire

2026’s Pivotal Fight For Religious Medical Freedom

Updated 4:46 AM EDT, Sat April 4, 2026

The framers of our Constitution incorporated two divine rights into the founding documents of America: religious freedom and church-state separation. The failed pandemic response strained these rights, and many others, for U.S. citizens seeking vaccine exemptions on religious grounds. The legal battles playing out over COVID-era religious violations and state-level moves to deny such rights…Continue reading 2026’s Pivotal Fight For Religious Medical Freedom

FLYING BLIND: FCC Still Uses Over 30-Year-Old Exposure Safety Limits to Greenlight 6G Radiation

Updated 11:58 AM EDT, Tue March 24, 2026

The failed story of safety science surrounding human radiofrequency radiation (RFR) [think cell phones, Wi-Fi, and smart meters] exposure limits allowed by the Federal Communications Commission (FCC) goes like this: “In the late 1990s, the FCC and ICNIRP adopted radiofrequency radiation (RFR) exposure limits to protect the public and workers from adverse effects of RFR.…Continue reading FLYING BLIND: FCC Still Uses Over 30-Year-Old Exposure Safety Limits to Greenlight 6G Radiation

Correcting the NY Times ACIP Reporting on Vaccine Injury; A point-by-point breakdown of one of the most poorly written NY Times articles

Updated 8:53 AM EDT, Mon March 16, 2026

Seeing Sunday’s NY Times headline titled Confidential Report Calls for Sweeping Changes to Track Covid Vaccine Harms, a reflexive question flashed in the minds of even the most staunch defenders of legacy vaccine policy – Is the NY Times about to dismiss the Covid vaccine injured? For those who don’t care to read the outlet’s…Continue reading Correcting the NY Times ACIP Reporting on Vaccine Injury; A point-by-point breakdown of one of the most poorly written NY Times articles

Nineteen Companies. Twenty-One Investigations. Zero Admissions of Wrongdoing.

For those who still need proof that the pharmaceutical industry views human health as a commodity and patients as revenue streams, a new review published in the Journal of Law, Medicine & Ethics just handed it to you—documented, sourced, and damning. The study abstract declared: “Reported bribes amounted to about US $12.6 million, with sanctions exceeding…Continue reading Nineteen Companies. Twenty-One Investigations. Zero Admissions of Wrongdoing.

Updated 9:24 AM EDT, Wed April 8, 2026

Your Body Was Never Broken. That Was the Point.

For decades, an increasingly unhealthy American public has been handed the same story. The human body is fragile, complicated, and largely dependent on medical intervention to function properly. Got a problem? Hold on, there’s a drug for that. Feeling run down? Probably a deficiency. Something more serious? Here’s a lifelong prescription. What we haven’t been…Continue reading Your Body Was Never Broken. That Was the Point.

Updated 4:02 AM EDT, Tue April 7, 2026

Ed Clay’s Hardest Fight: Former MMA Fighter Steps Into One of Medicine’s Most Controversial Frontiers

“Life is what happens when you’re making plans. This is one of those stories.” That’s how Del Bigtree introduced Ed Clay during a recent conversation on The HighWire, and it’s hard to think of a better way to describe the path that led Clay from professional fighting to running a regenerative medicine hospital. The Nashville-born…Continue reading Ed Clay’s Hardest Fight: Former MMA Fighter Steps Into One of Medicine’s Most Controversial Frontiers

Updated 2:32 PM EDT, Tue April 7, 2026

2026’s Pivotal Fight For Religious Medical Freedom

Updated 4:46 AM EDT, Sat April 4, 2026

Crossing the Blood-Brain Barrier: The Erythritol Problem

That “sugar-free” label center stage on the protein bar wrapper? Or the one promising guilt-free bit of sweetness in our morning cup of coffee? Well, it turns out that hailed sugar-free sweetener might be doing something our bodies—and our brains—were not designed to handle. Yes, we’re talking about erythritol, the innocent sweetener that sits in…Continue reading Crossing the Blood-Brain Barrier: The Erythritol Problem

Updated 12:26 PM EDT, Wed April 1, 2026

Tick Tock: Inside Pfizer’s Bid to Vaccinate Against Lyme

Pfizer is adding a new vaccine to its repertoire. The Big Pharma behemoth is preparing to bring a Lyme disease vaccine to market with its French partner, Valneva. The company recently announced the news, which comes at a time when public trust in pharmaceutical giants remains shaky, particularly following the contentious rollout of mRNA COVID…Continue reading Tick Tock: Inside Pfizer’s Bid to Vaccinate Against Lyme

Updated 12:27 PM EDT, Mon March 30, 2026